Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments...
HCAT: Q2 2026 beat guidance, divestiture enabled debt repayment, and 2026 outlook reflects transformation
Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates.
12 Health Care Stocks Moving In Thursday's After-Market Session
Health Catalyst Q2 FY26 net loss narrows 1% to $40.54 million; revenue falls 13% to $70.49 million
16:03 ETHealth Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Health Catalyst (HCAT) Q2 Earnings Report Preview: What To Look For